Grading of hemorrhage in children with idiopathic thrombocytopenic purpura.
about
Does treatment of newly diagnosed idiopathic thrombocytopenic purpura reduce morbidity?Severe bleeding events in adults and children with primary immune thrombocytopenia: a systematic reviewPhenotyping bleedingAdvances in ITP--therapy and quality of life--a patient surveyMeasurement of bleeding severity: a critical review.Prospective phase 1/2 study of rituximab in childhood and adolescent chronic immune thrombocytopenic purpuraPlatelet function to estimate the bleeding risk in autoimmune thrombocytopenia.Severe hemorrhage in children with newly diagnosed immune thrombocytopenic purpuraOne year follow-up of children and adolescents with chronic immune thrombocytopenic purpura (ITP) treated with rituximab.Effect of beta-blockers, Ca2+ antagonists, and benzodiazepines on bleeding incidence in patients with chemotherapy induced thrombocytopenia.Consensus Paper-ICIS Expert Meeting Basel 2009 treatment milestones in immune thrombocytopeniaRomiplostim in children with chronic refractory ITP: randomized placebo controlled study.Applicability of 2009 international consensus terminology and criteria for immune thrombocytopenia to a clinical pediatric populationResponse to steroids predicts response to rituximab in pediatric chronic immune thrombocytopeniaLegionellosis must be kept in mind in case of pneumonia with lung abscesses in children receiving therapeutic steroids.Reduced expression of transforming growth factor-β1 and correlated elevation of interleukin-17 and interferon-γ in pediatric patients with chronic primary immune thrombocytopenia (ITP).Platelet apoptosis in paediatric immune thrombocytopenia is ameliorated by intravenous immunoglobulin.Trends in anti-D immune globulin for childhood immune thrombocytopenia: usage, response rates, and adverse effects.Duration and morbidity of chronic immune thrombocytopenic purpura in children: five-year follow-up of a Nordic cohort.Management of children and adolescents with primary immune thrombocytopenia: controversies and solutions.Evaluation of children with chronic immune thrombocytopenic purpura and Evans syndrome treated with rituximab.Platelet count or bleeding as the outcome in ITP trials?Use of fresh platelet concentrate or lyophilized platelets in thrombocytopenic dogs with clinical signs of hemorrhage: a preliminary trial in 37 dogs.Bleeding severity as an important outcome in childhood immune thrombocytopenia.Standardized clinical assessment and management plans (SCAMPs): perspectives on a new method to understand treatment decisions and outcomes in immune thrombocytopenia.Romiplostim in children with chronic immune thrombocytopenia (ITP): the French experience.Evaluation of health related quality of life in children with immune thrombocytopenia with the PedsQL™ 4.0 Generic Core Scales: a study on behalf of the pays de Loire pediatric hematology network.Guidelines on the diagnosis of primary immune thrombocytopenia in children and adolescents: Associação Brasileira de Hematologia, Hemoterapia e Terapia Celular Guidelines Project: Associação Médica Brasileira - 2012.ITP-QoL questionnaire for children with immune thrombocytopenia: Italian version validation's.Health-related quality of life in children with newly diagnosed immune thrombocytopeniaSystematic analysis of bleeding phenotype in PT-VWD compared to type 2B VWD using an electronic bleeding questionnaire.Treatment and outcomes of immune cytopenias following solid organ transplant in children.Immune Thrombocytopenic Purpura in Children and Adults: A Comparative Retrospective Study in IRANFlow cytometric measurement of platelet-associated immunoglobulin in children with newly diagnosed Immune Thrombocytopenia.Platelet function tests, independent of platelet count, are associated with bleeding severity in ITP.Treatment of refractory ITP and Evans syndrome by haematopoietic cell transplantation: is it indicated, and for whom?Occult hemorrhage in children with severe ITP.Hospitalizations in pediatric patients with immune thrombocytopenia in the United States.Increasing observation rates in low-risk pediatric immune thrombocytopenia using a standardized clinical assessment and management plan (SCAMP® ).Childhood immune thrombocytopenia: A nationwide cohort study on condition management and outcomes.
P2860
Q24674173-9489AB33-5F88-455E-A72F-59CF7EACAC38Q26826853-845FE9F0-E17A-4CFF-8103-4744CD60C023Q26830732-D5ED8A7F-C107-49BB-AA59-1BB113830D61Q28742871-212791CC-2727-43CE-9FFC-FAAF9207C73EQ33360118-F66C909F-8069-4B00-8C29-77BB3C7250AFQ33369574-CED28088-CA82-4E55-9E7C-79288E74702AQ33376412-2CA1491B-42A1-4261-B0A8-58D8C34802DAQ33380732-855A1023-F71D-4934-AB3C-BC2F2A149E59Q33381700-B9B72BCE-34E9-4DE6-836B-43F53AC1FF5AQ33387124-6362A5BD-0258-4CDB-BBCE-4B048D4055B9Q33389001-221115D0-1915-4EF1-96D9-ED6A2E47B2EBQ33394122-826EABB8-90ED-4D32-90FD-BCEB049C9616Q33395789-18D6F207-107E-4FFF-A976-7365E1DF8B7EQ33395792-4991B04D-8999-4BE4-82CA-0553A85F1499Q33395991-1B5F7AA2-454B-4C37-B84B-83A935B18A3CQ33396043-C8F5F40E-DA65-475F-88A2-4DCF2ABE66C3Q33398769-8D37F219-8B04-41B5-B518-8F95A10EB423Q33398867-70350F27-B28B-44F8-B8B4-1679DFAD4E2BQ33400296-DE496F4E-DABD-446A-97F2-ED5F825E7DF6Q33402387-422029C8-783D-46FD-A8BA-EB8E785D79CCQ33402453-DE1AA7B0-BAAF-49C0-8EEF-1FDF73146E39Q33402594-1522A1E1-5DFE-4B67-A88E-8BF4DD78532FQ33403558-D71771A9-0925-4102-A009-C50FC15A487FQ33404101-5D86ABC7-1BAB-4D87-B0AF-D9196DB99C13Q33407632-79563E13-1DA9-44BA-9CA4-E3DA3933A8E7Q33411082-7A1A784D-C9E3-4824-8F1B-1DA0D19CA669Q33411434-101558D9-8356-4730-860D-9D7E382778E4Q33411617-67A1328B-878F-41CF-A5C7-498C7F81E5E8Q33415460-549A1F0F-BBBB-43ED-969F-5C29C92962B2Q33416038-51C12681-335F-4BD1-B9E0-1E2360A9A481Q33416741-FE6BCD3B-C6FF-4BB2-BF1B-3B4DEDCB0007Q33418159-8CEF49F8-FD4D-45E2-8BFF-50D6FFB8DA70Q33420128-A4F1C55B-7AC9-4DF5-8816-3D1120EA8F62Q33423880-85EBDBBC-BFEB-4CE8-9FB4-C31A91874D83Q33424115-A132D1B7-7F05-40A6-96E1-4DA9AF5995BDQ33424451-8EA66D2A-D4AE-49D5-BD81-2349AFACC833Q33428360-3DDCAE67-5B97-4A82-A177-8EE116EC8D6EQ33430486-8783F516-FE2D-40B3-85D8-C399EDF93396Q33436298-CC558266-53D9-47A2-9CCF-2BEA9A870961Q33437268-59A940D8-4CBD-4A41-99F6-9849DA1D62D4
P2860
Grading of hemorrhage in children with idiopathic thrombocytopenic purpura.
description
2002 nî lūn-bûn
@nan
2002 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Grading of hemorrhage in children with idiopathic thrombocytopenic purpura.
@ast
Grading of hemorrhage in children with idiopathic thrombocytopenic purpura.
@en
type
label
Grading of hemorrhage in children with idiopathic thrombocytopenic purpura.
@ast
Grading of hemorrhage in children with idiopathic thrombocytopenic purpura.
@en
prefLabel
Grading of hemorrhage in children with idiopathic thrombocytopenic purpura.
@ast
Grading of hemorrhage in children with idiopathic thrombocytopenic purpura.
@en
P356
P1476
Grading of hemorrhage in children with idiopathic thrombocytopenic purpura.
@en
P2093
George R Buchanan
P304
P356
10.1067/MPD.2002.128547
P407
P577
2002-11-01T00:00:00Z